Turkish Adaptation, Validity and Reliability of Community Integration Questionnaire-Revised (CIQ-R)
Launched by ISTANBUL MEDENIYET UNIVERSITY · Jun 22, 2022
Trial Information
Current as of April 28, 2025
Completed
Keywords
ClinConnect Summary
The reliability and validity of the scale will begin with language equivalence and cultural adaptation. The scale will be translated from English to Turkish by two people who are fluent in Turkish and English. A single Turkish translation will be obtained from these two Turkish translations with a common opinion.
The scale, which has been translated into Turkish, will be translated into English by two other people who are fluent in Turkish and English. The scale translated into English will be compared with the original. If the developer of the scale, Callaway and Willer approves the trans...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with
- • duration of hemiplegia ≤ 3 year
- • able to speak and read Turkish
- • those with a Mini Mental State Examination score of 24 and above
- • Exclusion Criteria: Patients with
- • communication or cognitive problems,
- • aphasia and speech disorders
- • unstable medical conditions
About Istanbul Medeniyet University
Istanbul Medeniyet University is a prominent academic institution based in Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct innovative studies aimed at improving healthcare outcomes. With a strong emphasis on ethical standards and scientific rigor, Istanbul Medeniyet University collaborates with healthcare professionals and researchers to explore new therapeutic strategies and contribute to the global body of medical knowledge. Their commitment to fostering a research-driven environment facilitates the development of cutting-edge treatments and enhances patient care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials